Purpose: To determine the impact and cost saving of clinical pharmacist’s intervention with infectious disease team, regarding treatment selection, dosing, renal and hepatic adjustments, Therapeutic drug monitoring and patient follow up.
Methods: 1. This is a prospective observational study from February 2010 to June 2012.In this study the clinical pharmacist daily rounded with infectious disease team, make and documents interventions for patients in medical, surgical and intensive care units. 2. the Clinical pharmacist interventions includes treatment selection, appropriate dose, renal and hepatic dose adjustments, TDM and patient education and follow up for any side effects. 3. All intervention data were entered and analyzed using SPSS program version 20.
Results: Over more than 700 rounding days the clinical pharmacist made over than 950 interventions.49 % of interventions related to drug dosing, 16.2 % of interventions dealing with determining the duration of therapy, 12.7 % related to writing prescriptions and 7.5 % for therapeutic drug monitoring. Some of interventions data were lost because the unavailability of SPSS program during months June, July and august 2011.
Conclusion: The clinical pharmacist has a huge impact and great role with infectious disease team leading to better patient care and optimal outcomes .total number of intervention were more than 950 clinical interventions over 700 rounding days .this study empathizes on the great role of clinical pharmacist with recommendation to hire more clinical pharmacists to cover other specialty teams .